South Korea Biobanks Market Size, Share, and COVID-19 Impact Analysis, By Product (LIMS, Biobanking Equipment), By Biospecimen Type (Organs, Stem Cells), By Application (Therapeutics, Drug Discovery & Clinical Research, and Clinical Diagnostics), and South Korea Biobanks Market Insights, Industry Trend, Forecasts To 2035

South Korea Biobanks Market Insights Forecasts to 2035

• The Market Size is Expected to Grow at a CAGR of around 9.3% from 2025 to 2035
• The South Korea Biobanks Market size is expected to hold a significant share by 2035

According to a research report published by Spherical Insights & Consulting, the South Korea Biobanks Market Size is anticipated to grow at a CAGR of 9.3% from 2025 to 2035. The market is driven by significant expenditures on the research and development of cutting-edge treatments, including personalized medicine, regenerative medicine, and cancer genomic studies are raising the demand for the French biobank market.

Market Overview

A biobank is a safe biorepository containing such biological materials as DNA, blood, plasma, and tissue. It plays an essential role in medical development and research by furnishing important resources to research gene, environment, and lifestyle effects on a person's health. Researchers utilize the information gathered in biobanks to pose questions, investigate, and gain new knowledge. These research findings are then fed back into the biobank and become more valuable. Korea's Korea Biobank Project (KBP) and National Biobank of Korea (NBK) have since 2008 built a network of regional and public hospital biobanks to support precision medicine and R&D healthcare. The Osong Life Science Complex is a national policy to construct bio-clusters, bridging biobanking and biotech innovation and business development.

Report Coverage

This research report categorizes the market for the South Korea biobanks market based on various segments and regions and forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the South Korea biobanks market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the South Korea biobanks market.

Driving Factors

One of the primary drivers for the South Korea Biobank Market is expansion in precision medicine and personalized treatment strategies, where South Korea's emphasis on bringing together genomic information and clinical results is pushing significant demand for high-quality, well-annotated biospecimens. Further, government funding towards genomic sequencing, particularly Korea Biobank Project and National Cohort Project, is increasing research capabilities and supporting biobank infrastructure. Pharma and academic collaboration in drug development and biomarker discovery also supports the biobank ecosystem. Increasingly, technological advancements in sample storage, digital biobanking, and real-time access are redefining static models of biobanks as dynamic data-driven research platforms.

Restraining Factors

Even with the increasing market, the market is confronted with such issues as regulatory and ethical issues regarding privacy, data control, and informed consent. There are privacy laws and regulatory bioethics in South Korea that, although safeguarding donor rights, may retard sample extraction and international cooperation. Moreover, the absence of standardization among regional biobanks in the processing of the samples, data annotation, and IT systems may retard interoperability and scalability. Both the high cost of operation, limited public knowledge, and practicability in long-term financing also pose probable obstacles to market expansion.

Market Segmentation

The South Korea biobanks market share is classified into product, biospecimen type, and application.

• The biobanking equipment segment is expected to hold the largest share of the global biobanks market during the forecast period. 

The South Korea biobanks market is segmented by product into LIMS and biobanking equipment. Among these, the biobanking equipment segment is expected to hold the largest share of the global biobanks market during the forecast period. Biobanking equipment plays a critical role in the efficient storage and preservation of biological samples. With features like storage systems, transportation solutions for samples, and processing equipment that guarantee sample integrity and viability, the biobanking equipment is a must-have machine for biobanks. Increased developments in cryopreservation technologies and automation choices have contributed greatly to the efficiency and reliability of biobanking functions. Further, the growing need for automation and regulatory requirements call for advanced biobanking equipment implementation.

• The stem cells segment is expected to hold the largest share of the global biobanks market during the forecast period.

The South Korea biobanks market is segmented by biospecimen type into organs and stem cells. Among these, the stem cells segment is anticipated to hold the largest share of the South Korea biobanks market during the forecast period. Stem cells are unique body cells that can differentiate into other cells, like muscle cells, blood cells, and brain cells. Stem cells also give a promise for applications in regenerative medicine and are thus vital to much research and therapy circumstances. For instance, advancements in stem cell therapies for diseases like Parkinson's, diabetes, and heart disease enhance segmental growth. Their significance is evidenced by their use in clinical trials and research towards medical applications, and investment in stem cell biobanking.

• The drug discovery & clinical research segment is expected to grow at the fastest CAGR in the global biobanks market during the forecast period.

The South Korea biobanks market is segmented by application into therapeutics, drug discovery & clinical research, and clinical diagnostics. Among these, the drug discovery & clinical research segment is expected to grow at the fastest CAGR in the global biobanks market during the forecast period. The speedy development is attributed to growing reliance on biobanks for the development of new drugs and optimization of existing drugs. Biobanks offer well-characterized, high-quality biological samples that are critical for understanding disease mechanisms and the identification of targeted treatment objectives. Greater precision medicine demands complete repositories of data and samples, speeding up drug discovery processes. Also included are newer technologies like genomics, proteomics, and bioinformatics in clinical research that have enhanced the potential for analysis and utilization of biobank samples most usefully.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the South Korea biobanks market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Korea National Institute of Health (KNIH)
• Seoul National University Hospital Biobank
• Samsung Medical Center Biobank
• Asan Medical Center Biobank
• Yonsei University Severance Hospital Biobank
• CHA Bio Complex Biobank
• Korea Institute of Science and Technology (KIST)
• Korea Research Institute of Bioscience and Biotechnology (KRIBB)
• BioInfra Co., Ltd.
• Macrogen Inc.
• 0thers

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Market Segment

This study forecasts revenue at South Korea, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the South Korea biobanks market based on the below-mentioned segments:

South Korea Biobanks Market, By Product

• LIMS
• Biobanking Equipment

South Korea Biobanks Market, By Biospecimen Type

• Organs
• Stem Cells

South Korea Biobanks Market, By Application

• Therapeutics
• Drug Discovery & Clinical Research
• Clinical Diagnostics